Glenmark releases generic Travatan Z
Generic Travatan Z is indicated for glaucoma and hypertension in the eye.
Glenmark Pharmaceuticals is introducing travoprost ophthalmic solution, 0.004% (ionic buffered solution), which is the generic of Sandoz’s Travatan Z.
The medication is indicated for glaucoma and hypertension in the eye.
Travatan Z had a market value of approximately $66.2 million for the 12 month period ending September 2024, per IQVIA.
[Read more: Glenmark debuts Olopatadine Hydrochloride Ophthalmic Solution OTC]
Jim Brown, senior vice president, sales and marketing said, “We are excited to announce the launch of Travoprost Ophthalmic Solution USP, 0.004%, growing our portfolio of prescription ophthalmic products. This addition highlights our commitment to meeting market needs and providing high-quality solutions for our customers.”